BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 299940)

  • 21. Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.
    Dowling SV; Muntz RH; D'Souza S; Ekert H
    Thromb Diath Haemorrh; 1975 Nov; 34(2):465-74. PubMed ID: 1081746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the von Willebrand factor in atherogenesis.
    Green D
    Artery; 1979 Mar; 5(3):262-72. PubMed ID: 316693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Simple rapid test for assaying ristocetin cofactor].
    Aznar JA; Borrego D; Martín G; Jorquera J; Jiménez C; García I; Marty ML
    Sangre (Barc); 1982; 27(5):959-66. PubMed ID: 6984787
    [No Abstract]   [Full Text] [Related]  

  • 24. [Multimeric structure of factor VIII/von Willebrand factor released from human platelets by ADP, collagen and thrombin].
    López Fernández MF; Batlle Fonrodona FJ; Ginsberg MH; Ruggeri ZM; Zimmerman TS
    Sangre (Barc); 1983; 28(4):439-49. PubMed ID: 6419355
    [No Abstract]   [Full Text] [Related]  

  • 25. Letter: A method for assaying von Willebrand factor (ristocetin cofactor).
    Macfarlane DE; Stibbe J; Kirby EP; Zucker MB; Grant RA; McPherson J
    Thromb Diath Haemorrh; 1975 Sep; 34(1):306-8. PubMed ID: 1081281
    [No Abstract]   [Full Text] [Related]  

  • 26. [On the platelet function in von Willebrand-Juergen's syndrome--Discussion].
    Winckelmann G
    Hamatol Bluttransfus; 1969; 6():196-9. PubMed ID: 5306342
    [No Abstract]   [Full Text] [Related]  

  • 27. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
    Shihong I; Morris D; Konkle BA
    Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time for a redefinition of type 2M von Willebrand disease.
    Keeling D
    Br J Haematol; 2002 Sep; 118(3):922. PubMed ID: 12181067
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparison of two methods for measurement of von Willebrand's factor (ristocetin cofactor).
    Dowling SV; Ekert H
    Thromb Haemost; 1976 Aug; 36(1):284-5. PubMed ID: 1087476
    [No Abstract]   [Full Text] [Related]  

  • 30. [Determination of the von Willebrand factor].
    Turek P; Sikorová J; Vorlová Z
    Vnitr Lek; 1984 Jun; 30(6):550-6. PubMed ID: 6332414
    [No Abstract]   [Full Text] [Related]  

  • 31. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].
    Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of von Willebrand factor in plasma and platelets of cats.
    Waters DC; Eaton AH; Steidley KR; McCarroll DR
    Am J Vet Res; 1989 Feb; 50(2):201-4. PubMed ID: 2785779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between bleeding time and platelet adherence to artery subendothelium.
    Sakariassen KS; Bolhuis PA; Blombäck M; Thorell L; Blombäck B; Sixma JJ
    Thromb Haemost; 1984 Oct; 52(2):144-7. PubMed ID: 6441301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retention test Homburg to monitor the adhesive properties of von Willebrand factor after substitution or desmopressin therapy.
    Wieding JU; Matern J; Köstering H; Wermes C; Wenzel E
    Semin Thromb Hemost; 2005; 31(4):441-8. PubMed ID: 16149022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2.
    van Vliet HH; Kappers-Klunne MC; Leebeek FW; Michiels JJ
    Thromb Haemost; 2008 Sep; 100(3):462-8. PubMed ID: 18766263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnostic strategies for detection of the von Willebrand syndrome].
    Eller T; Mayer J; Bomhard M; Keller F
    Beitr Infusionsther; 1992; 30():268-71. PubMed ID: 1284714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Properties of the platelet retention (von Willebrand) factor and its similarity to the antihemophilic factor (AHF).
    Weiss HJ; Rogers J; Brand H
    Blood; 1973 Jun; 41(6):809-15. PubMed ID: 4541271
    [No Abstract]   [Full Text] [Related]  

  • 38. [Determination of von Willebrand factor].
    Kajikawa M; Kuramoto J
    Nihon Rinsho; 1979 Jun; Suppl():2210-1. PubMed ID: 315005
    [No Abstract]   [Full Text] [Related]  

  • 39. Laboratory approach to platelet disorders.
    Davey FR
    Postgrad Med; 1973 Aug; 54(2):109-12 passim. PubMed ID: 4541725
    [No Abstract]   [Full Text] [Related]  

  • 40. [Platelet adhesion and aggregation].
    David JL
    Acta Clin Belg; 1977; 32(6):363-74. PubMed ID: 211769
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.